Fleury H - Search Results

1

Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort.

Peuchant O, Capdepont S, Ragnaud JM, Aurillac-Lavignolle V, Thiébaut R, Fleury H, Masquelier B; ANRS CO3 Aquitaine Cohort. Peuchant O, et al. Among authors: fleury h. Antivir Ther. 2007;12(4):559-62. doi: 10.1177/135965350701200413. Antivir Ther. 2007. PMID: 17668565

2

An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.

Capdepont S, Aurillac-Lavignolle V, Faure M, Dupon M, Morlat P, Ragnaud JM, Chêne G, Fleury H, Masquelier B; GECSA. Capdepont S, et al. Among authors: fleury h. J Clin Virol. 2006 May;36(1):36-42. doi: 10.1016/j.jcv.2006.01.008. Epub 2006 Feb 28. J Clin Virol. 2006. PMID: 16513416

3

Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort.

Balestre E, Dupon M, Capdepont S, Thiébaut R, Boucher S, Fleury H, Dabis F, Masquelier B; GECSA. Balestre E, et al. Among authors: fleury h. J Clin Virol. 2006 Jun;36(2):95-9. doi: 10.1016/j.jcv.2006.02.002. Epub 2006 Mar 23. J Clin Virol. 2006. PMID: 16556509

4

Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.

Masquelier B, Neau D, Boucher S, Lavignolle-Aurillac V, Schrive MH, Recordon-Pinson P, Ragnaud JM, Fleury H. Masquelier B, et al. Among authors: fleury h. Antivir Ther. 2006;11(6):827-30. Antivir Ther. 2006. PMID: 17310827 Clinical Trial.

5

Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).

Pellegrin I, Wittkop L, Joubert LM, Neau D, Bollens D, Bonarek M, Girard PM, Fleury H, Winters B, Saux MC, Pellegrin JL, Thiébaut R, Breilh D; ANRS Co3 Aquitaine Cohort. Pellegrin I, et al. Among authors: fleury h. Antivir Ther. 2008;13(2):271-9. Antivir Ther. 2008. PMID: 18505178

6

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.

Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B; ANRS CO3 Aquitaine Cohort. Peuchant O, et al. Among authors: fleury h. AIDS. 2008 Jul 31;22(12):1417-23. doi: 10.1097/QAD.0b013e3283034953. AIDS. 2008. PMID: 18614864 Free article.

7

HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.

Recordon-Pinson P, Anies G, Bruyand M, Neau D, Morlat P, Pellegrin JL, Groppi A, Thiébaut R, Dabis F, Fleury H, Masquelier B; ANRS CO3 Aquitaine Cohort. Recordon-Pinson P, et al. Among authors: fleury h. Antivir Ther. 2009;14(4):551-6. Antivir Ther. 2009. PMID: 19578240

8

HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs.

Fleury H, Recordon-Pinson P, Caumont A, Faure M, Roques P, Plantier JC, Couturier E, Dormont D, Masquelier B, Simon F; Agence Nationale de Recherche sur le SIDA AC11 Laboratory Network. Fleury H, et al. AIDS Res Hum Retroviruses. 2003 Jan 1;19(1):41-7. doi: 10.1089/08892220360473952. AIDS Res Hum Retroviruses. 2003. PMID: 12596719

9

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.

Masquelier B, Pereira E, Peytavin G, Descamps D, Reynes J, Verdon R, Fleury H, Garraffo R, Chêne G, Raffi F, Brun-Vézinet F; APROCO/COPILOTE Study Group. Masquelier B, et al. Among authors: fleury h. J Clin Virol. 2005 May;33(1):75-8. doi: 10.1016/j.jcv.2004.11.012. J Clin Virol. 2005. PMID: 15797369 Clinical Trial.

10

Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

Masquelier B, Bhaskaran K, Pillay D, Gifford R, Balestre E, Jørgensen LB, Pedersen C, van der Hoek L, Prins M, Balotta C, Longo B, Kücherer C, Poggensee G, Ortiz M, de Mendoza C, Gill J, Fleury H, Porter K; CASCADE Collaboration. Masquelier B, et al. Among authors: fleury h. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):505-11. doi: 10.1097/01.qai.0000186361.42834.61. J Acquir Immune Defic Syndr. 2005. PMID: 16284524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters